These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33608769)

  • 1. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.
    Chen Y; Zhang P; Wang J; Gong Q; An Y; Qian X; Zhang B; Li H; Gregg EW; Bennett PH; Li G
    Diabetologia; 2021 Jun; 64(6):1279-1287. PubMed ID: 33608769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].
    Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G
    Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of improvement or worsening of glucose tolerance on risk of stroke in persons with impaired glucose tolerance.
    Shen X; Zhang P; Wang J; An Y; Gregg EW; Zhang B; Li H; Gong Q; Chen Y; Shuai Y; Engelgau MM; Hu Y; Bennett PH; Li G
    Int J Stroke; 2018 Dec; 13(9):941-948. PubMed ID: 29956594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.
    Li G; Zhang P; Wang J; An Y; Gong Q; Gregg EW; Yang W; Zhang B; Shuai Y; Hong J; Engelgau MM; Li H; Roglic G; Hu Y; Bennett PH
    Lancet Diabetes Endocrinol; 2014 Jun; 2(6):474-80. PubMed ID: 24731674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: A post hoc analysis of Da Qing Diabetes Prevention Outcome Study.
    Gong Q; Zhang P; Wang J; Gregg EW; Cheng YJ; Li G; Bennett PH;
    Diabetes Obes Metab; 2021 Oct; 23(10):2385-2394. PubMed ID: 34212465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subjects with impaired glucose tolerance returned to normal glucose status for six years had lower long-term risk of diabetes: 20 years follow up of Daqing diabetes prevention study].
    Shen XX; Wang JP; Chen YY; An YL; Gong QH; Zhang B; Hong J; Shuai Y; Zhao F; Li H; Li GW
    Zhonghua Nei Ke Za Zhi; 2019 May; 58(5):372-376. PubMed ID: 31060146
    [No Abstract]   [Full Text] [Related]  

  • 8. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
    Gong Q; Zhang P; Wang J; Ma J; An Y; Chen Y; Zhang B; Feng X; Li H; Chen X; Cheng YJ; Gregg EW; Hu Y; Bennett PH; Li G;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):452-461. PubMed ID: 31036503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study.
    Qian X; Wang J; Gong Q; An Y; Feng X; He S; Chen X; Wang W; Zhang L; Hui Y; Zhai X; Zhang B; Chen Y; Li G
    PLoS Med; 2024 Jul; 21(7):e1004419. PubMed ID: 38980837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
    Pan XR; Li GW; Hu YH; Wang JX; Yang WY; An ZX; Hu ZX; Lin J; Xiao JZ; Cao HB; Liu PA; Jiang XG; Jiang YY; Wang JP; Zheng H; Zhang H; Bennett PH; Howard BV
    Diabetes Care; 1997 Apr; 20(4):537-44. PubMed ID: 9096977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward?
    Wong MS; Gu K; Heng D; Chew SK; Chew LS; Tai ES
    Diabetes Care; 2003 Nov; 26(11):3024-30. PubMed ID: 14578234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein predicts the deterioration of glycemia in chinese subjects with impaired glucose tolerance.
    Tan KC; Wat NM; Tam SC; Janus ED; Lam TH; Lam KS
    Diabetes Care; 2003 Aug; 26(8):2323-8. PubMed ID: 12882856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of a diet and/or exercise intervention on long-term mortality and vascular complications in people with impaired glucose tolerance: Da Qing Diabetes Prevention Outcome study.
    Yu L; Wang J; Gong Q; An Y; Chen F; Chen Y; Chen X; He S; Qian X; Chen B; Dong F; Li H; Zhao F; Zhang B; Li G;
    Diabetes Obes Metab; 2024 Apr; 26(4):1188-1196. PubMed ID: 38168886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging.
    Meigs JB; Muller DC; Nathan DM; Blake DR; Andres R;
    Diabetes; 2003 Jun; 52(6):1475-84. PubMed ID: 12765960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer and its predictors in Chinese adults with newly diagnosed diabetes and impaired glucose tolerance (IGT): a 30-year follow-up of the Da Qing IGT and Diabetes Study.
    He S; Wang J; Shen X; Qian X; An Y; Gong Q; Zhang B; Chen B; Zhang L; Chen X; Chen Y; Li G
    Br J Cancer; 2022 Jul; 127(1):102-108. PubMed ID: 35256755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
    Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
    Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early improvement predicts reduced risk of incident diabetes and improved cardiovascular risk in prediabetic Asian Indian men participating in a 2-year lifestyle intervention program.
    Nanditha A; Ram J; Snehalatha C; Selvam S; Priscilla S; Shetty AS; Arun R; Godsland IF; Johnston DG; Ramachandran A
    Diabetes Care; 2014 Nov; 37(11):3009-15. PubMed ID: 25216506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Type 2 Diabetes is Higher among Men with Persistent Impaired Glucose Tolerance than in Transient Impaired Glucose Tolerance - A 5 year Follow up Study.
    Raghavan A; Nanditha A; Snehalatha C; Vinitha R; Susairaj P; Simon M; Selvam S; Satheesh K; Ram J; Kumar APN; Godsland IF; Oliver N; Johnston DG; Ramachandran A
    J Assoc Physicians India; 2018 Oct; 66(10):22-26. PubMed ID: 31317702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.